A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether off-pump coronary artery bypass grafting with coronary endarterectomy (OPCAB-CE) is a safe and feasible method of myocardial revascularization in patients presenting with diffuse coronary artery disease. Seventy-one papers were identified by a systematic search, of which nine were judged to best answer the clinical question. All were observational studies. Of these, two were comparative and the remaining seven were case series. The authors, journal, date, country of publication, patient group, study type, relevant outcomes and results were tabulated. In total, these 9 studies included 341 patients (225 OPCAB-CE, 116 ONCAB-CE) undergoing coronary endarterectomy in combination with coronary artery bypass grafting. CE was performed either by an open method whereby the atheroma is removed through an arteriotomy made along the length of the stenosis or by a closed method whereby the atheroma is removed by gentle traction through a small arteriotomy made over a proximal area of the plaque. Overall, OPCAB-CE was associated with a low perioperative mortality ranging from zero in smaller case series to 2.8% in the largest study (n = 70). Two comparative studies demonstrate at least equivalent 30-day mortality between OPCAB-CE and ONCAB-CE, although the sample sizes are small. The overall incidence of postoperative myocardial infarction (MI) was 6.1% (11/180) and seems comparable between OPCAB-CE and ONCAB-CE. Notably, both postoperative MI and mortality appeared higher in patients undergoing multiple endarterectomies performed using a closed technique and CE to the right coronary artery was associated with increased postoperative MI. In summary, OPCAB-CE in the setting of diffuse coronary artery disease appears both safe and feasible, yielding comparable results to ONCAB-CE. Where possible, open arteriotomy with on-lay patch angioplasty may improve postoperative outcomes. Large, prospective database studies are now required with explicit sub-group criteria and stratification to number, territory and technique of endarterectomy in order to isolate the patients in whom OPCAB-CE may confer the greatest benefit.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol as fully described in the ICVTS [1] .
THREE-PART QUESTION
In [ patients presenting with diffuse coronary artery disease], is [off-pump coronary artery bypass with coronary endarterectomy] or [on-pump coronary bypass with coronary endarterectomy] the best method in terms of [survival and freedom from myocardial infarction]?
CLINICAL SCENARIO
A 65-year old man with a history of two previous anterior myocardial infarctions (MIs) is referred with worsening exertional chest pain. His percutaneous coronary angiogram reveals triple-vessel disease with a long segment of diffuse left anterior descending coronary artery (LAD) stenosis. Transthoracic echo shows a hypokinetic anterior wall and an ejection fraction of 35%. You are asked to consider him for elective CABG. You suspect that you may have to perform coronary endarterectomy and your trainee asks whether you would perform this case 'off-pump'? 
RESULTS
Vohra et al. [10] prospectively studied 70 patients undergoing predominantly single-vessel (66/70) coronary endarterectomy (CE) in combination with on-pump coronary artery bypass grafting (OPCAB). Perioperative mortality was 2.8% (2/70), with a low incidence of cerebrovascular accident (1/70) and perioperative MI (3/ 70). Both mortalities occurred in those who received CE to right coronary artery (RCA). One-year and 5-year survival were 91.5 and 87.9%, respectively. Patients undergoing CE had significantly higher mortality and MI when compared with OPCAB without CE (mortality 8/610; MI 5/610).
In their retrospective study of 42 patients with poor ejection fraction (mean 29.7%) undergoing OPCAB-CE, Kunt et al. [6] observed 12% overall mortality (5/42) and perioperative MI occurring in 10% (4/42). Such high morbidity and mortality may have resulted from frequent multiple endarterectomies (43%) performed using a closed arteriotomy technique. Overall patency of endarterectomized vessels at 28.4 months was 89%, and 5-year survival was 79%.
Nurozler et al. [8] retrospectively studied 32 patients undergoing OPCAB-CE with moderate ventricular impairment (ejection fraction (EF) 38.6%). The mean number of CEs performed per patient was 1.18 ± 0.2. One patient died postoperatively, and 1 suffered a postoperative stroke. Two postoperative myocardial infarctions occurred, both in the RCA territory. Again, these MIs were attributed to using a closed endarterectomy technique when addressing the RCA. Freedom from cardiac events requiring hospital readmission was 89%. Only 3 of 32 patients underwent follow-up angiography although all endarterectomized vessels were patent at this time.
In their retrospective series of 12 patients (EF 51 ± 15%) who underwent OPCAB-CE, Takahashi et al. [9] reported 100% survival without any postoperative myocardial infarction or stroke. However, all were single-vessel LAD endarterectomies performed using an open technique with subsequent on-lay patch angioplasty (left internal thoracic artery patch). Only 2 patients received followup angiography, both of which demonstrated patency of the endarterectomised vessel.
Eryilmaz et al. [4] retrospectively studied 11 patients (EF 26.3 ± 4.4%) who underwent predominantly LAD (n = 7/11) OPCAB-CE using an open technique with on-lay patch angioplasty. There was no hospital death or MI. Considerable improvement was observed in Canadian Cardiovascular Society grading of angina status grade, NYHA functional classification and mean EF (P < 0.05) postoperatively. One-year patency of grafts to endarterectomized coronary vessels was 95.6% (n = 22/23).
Reyna et al. [2] performed nine closed endarterectomies with OPCAB on 8 patients, 6 of which were to the RCA. There were no hospital deaths; however, postoperative MI occurred in 1 patient. All patients were asymptomatic upon discharge.
Darwazah et al. [3] performed seven closed endarterectomies with OPCAB on 5 patients with poor EF (27 ± 4.5%), predominantly to the LAD (n = 5/7). There were no hospital deaths, although 1 perioperative MI occurred in a patient receiving multiple endarterectomy. One-year patency of grafts to endarterectomized coronary vessels was 83.4% (n = 6/7).
Comparing on-pump coronary artery bypass grafting to off-pump coronary artery bypass grafting Naseri et al. [7] retrospectively studied 88 patients undergoing either on-(n = 44) or off-(n = 44) pump CE. Overall 30-day mortality was 3.4% (3/88; 1 OPCAB; 2 ONCAB), with postoperative MI occurring in 5.7% (5/88; 3 OPCAB; 2 ONCAB). Perioperative neurological deficit occurred in 8.0% (7/88) all of which were in the ONCAB group. The authors conclude that OPCAB-CE confers comparable safety to ONCAB endarterectomy.
Similarly, in their prospective study of 115 patients (43 OPCAB; 72 ONCAB), Hussain et al. [5] observed comparable mortality (P = 0.649), MI (P = 0.576), AF (P = 0.197), IABP use (P = 0.295) and respiratory complications (P = 0.211) between OPCAB-CE and ONCAB-CE. OPCAB-CE was associated with reduced ITU stay (P = 0.007) and a trend towards a shorter intubation period (P = 0.060) and reduced postoperative renal failure (P = 0.075).
CLINICAL BOTTOM LINE
The application of adjunct CE remains controversial due to concerns over high morbidity and mortality. Avoidance of cardiopulmonary bypass may be particularly beneficial in high-risk patients with poor EF whereby OPCAB may reduce global myocardial ischaemia, lower transfusion requirements and improve short-term morbidity [11] . We sought to assess the safety and feasibility of OPCAB-CE in selected patients with diffuse multivessel disease.
OPCAB-CE was associated with a low perioperative mortality ranging from zero in smaller case series [2] [3] [4] 9 ] to 2.8% in the largest study [10] . Furthermore, comparative studies demonstrate at least equivalent 30-day mortality between OPCAB-CE and ONCAB-CE [5, 7] . Notably however, multiple-vessel endarterectomy performed using a closed technique was potentially associated with higher mortality (12%) [6] .
Postoperative MI resulting from embolization of atheromatous debris or de novo thrombogonenesis remains a fundamental concern following CE. Among these best evidence series, the overall incidence of postoperative MI was 6.1% (11/180). Increased incidence of postoperative MI was particularly notable in patients undergoing multiple endarterectomies [3, 6] , RCA endarterectomy [8] and endarterectomy performed using a closed approach [6, 8] . Notably, however, MI rates were comparable between OPCAB and ONCAB techniques [5, 7] .
Several limitations must be considered. All studies were small sized, non-randomized and retrospective. Furthermore, variable selection criteria, patient demographics, surgical technique and institutional experience may have an unmeasurable effect on outcomes.
In summary, OPCAB-CE in the setting of diffuse coronary artery disease appears both safe and feasible, yielding results comparable with those of ONCAB-CE. Where possible, open arteriotomy with on-lay patch angioplasty may improve postoperative outcomes although it should be noted that the level of available evidence is currently poor. Large, prospective database studies are now required to isolate the outcomes of OPCAB-CE in defined subgroups stratifying the number, territory and technique of endarterectomy in order to isolate the patients in whom OPCAB-CE may confer the greatest benefit and determine long-term graft patency.
